Kirsten L. Viola

This paper demonstrates that amyloid β oligomers (AβOs) are key drivers of Alzheimer's disease pathology and shows that AβO-selective antibodies can restore memory function and serve as diagnostic tools.

This study identifies lysine succinylation as a post-translational modification linked to amyloid and tau pathology in Alzheimer's disease through human brain and mouse model analyses.